Loading...
Stryker reported an 11.8% increase in net sales to $5.8 billion and a 102.7% increase in EPS to $2.98 for Q4 2023. Organic net sales grew by 11.4%. The company surpassed $20 billion in sales for the full year and expects continued growth in 2024.
Net sales increased by 11.8% to $5.8 billion.
Organic net sales increased by 11.4%.
Reported EPS increased by 102.7% to $2.98.
Adjusted EPS increased by 15.3% to $3.46.
Stryker expects 2024 organic net sales growth to be in the range of 7.5% to 9.0% and adjusted net earnings per diluted share to be in the range of $11.70 to $12.00.